处方类阿片药物使用与腰痛关联——两样本孟德尔随机化分析
摘要
系。通过遗传变异作为工具变量,模拟随机对照试验,以克服观察性研究中混杂因素的影响,从而更准确地评估阿
片类药物对腰痛风险的潜在因果作用。方法:本研究使用来自英国生物银行(UKB)的病例对照全基因组关联研
究(GWAS)汇总统计数据,包含78,808名参与者(22,982例阿片类药物使用者和55,826例非使用者)。腰痛的
结局数据来自芬兰生物库的GWAS结果,包含42,521例病例组和353,224例对照组。通过多种孟德尔随机化方法
(IVW、加权中值法、MR Egger)分析因果关系。结果:逆方差加权法(IVW)显示阿片类药物使用显著增加腰痛
的风险(OR=1.146,95% CI 95% CI[1.086,1.209],p<0.01)。加权中值法的结果支持这一发现(OR=1.119,95% CI
[1.029,1.216],p<0.01)。异质性及水平多效性分析未发现显著偏倚(MR Egger截距=0.00263,p=0.64,Cochran Q
检验p=0.401),整体因果估计结果稳健。讨论:本研究通过MR方法提供了处方阿片类药物使用与腰痛风险增加的
因果关联证据。研究结果支持了减少阿片类药物用于腰痛管理的必要性,并提示未来在特定人群中的进一步验证研
究,以帮助优化临床疼痛管理策略。
关键词
全文:
PDF参考
[1]Global, regional, and national incidence, prevalence,
and years lived with disability for 354 diseases and injuries for
195 countries and territories, 1990-2017: a systematic analysis
for the Global Burden of Disease Study 2017 [J]. Lancet
(London, England), 2018, 392(10159): 1789-858.
[2]EDWARDS J, HAYDEN J, ASBRIDGE M, et
al. Prevalence of low back pain in emergency settings: a
systematic review and meta-analysis [J]. BMC Musculoskelet
Disord, 2017, 18(1): 143.
[3]FOSTER N E, ANEMA J R, CHERKIN D, et
al. Prevention and treatment of low back pain: evidence,
challenges, and promising directions [J]. Lancet, 2018,
391(10137): 2368-83.
[4]DEYO R A, VON KORFF M, DUHRKOOP D.
Opioids for low back pain [J]. BMJ, 2015, 350: g6380.
[5]KNEZEVIC N N, CANDIDO K D, VLAEYEN J W S,
et al. Low back pain [J]. Lancet, 2021, 398(10294): 78-92.
[6]JONES C M P, DAY R O, KOES B W, et al.
Opioid analgesia for acute low back pain and neck pain
(the OPAL trial): a randomised placebo-controlled trial [J].
Lancet, 2023, 402(10398): 304-12.
[7]CHOU R, TURNER J A, DEVINE E B, et al.
The effectiveness and risks of long-term opioid therapy for
chronic pain: a systematic review for a National Institutes
of Health Pathways to Prevention Workshop [J]. Annals of
Internal Medicine, 2015, 162(4): 276-86.
[8]WANG Z, FENG W, JIN Q. Occupational factors
and low back pain: a Mendelian randomization study [J].
Front Public Health, 2023, 11: 1236331.
[9]SEKULA P, DEL GRECO M F, PATTARO C,
et al. Mendelian Randomization as an Approach to Assess
Causality Using Observational Data [J]. J Am Soc Nephrol,
2016, 27(11): 3253-65.
[10]WU Y, BYRNE E M, ZHENG Z, et al. Genomewide association study of medication-use and associated disease
in the UK Biobank [J]. Nat Commun, 2019, 10(1): 1891.
[11]CAI J, HE L, WANG H, et al. Genetic liability for
prescription opioid use and risk of cardiovascular diseases: a
multivariable Mendelian randomization study [J]. Addiction,
2022, 117(5): 1382-91.
[12]LUO G, YAO Y, TAO J, et al. Causal association
of sleep disturbances and low back pain: A bidirectional twosample Mendelian randomization study [J]. Front Neurosci,
2022, 16: 1074605.
[13]GIBSON M, MUNAFO M R, TAYLOR A E,
et al. Evidence for Genetic Correlations and Bidirectional,
Causal Effects Between Smoking and Sleep Behaviors [J].
Nicotine Tob Res, 2019, 21(6): 731-8.
[14]HARTWIG F P, BORGES M C, HORTA B L,
et al. Inflammatory Biomarkers and Risk of Schizophrenia:
A 2-Sample Mendelian Randomization Study [J]. JAMA
Psychiatry, 2017, 74(12): 1226-33.
[15]BOHNERT A S B, GUY G P, JR., LOSBY J L.
Opioid Prescribing in the United States Before and After the
Centers for Disease Control and Prevention’s 2016 Opioid
Guideline [J]. Ann Intern Med, 2018, 169(6): 367-75.
[16]GOESLING J, HENRY M J, MOSER S E, et al.
Symptoms of Depression Are Associated With Opioid Use
Regardless of Pain Severity and Physical Functioning Among
Treatment-Seeking Patients With Chronic Pain [J]. J Pain,
2015, 16(9): 844-51.
Refbacks
- 当前没有refback。